"3 by 5" progress December 2005

Number of people receiving ARV therapy Antiretroviral therapy coverage in low- and middle-income countries, December 2005 Geographical Region Number of people receiving ARV therapy Estimated need Coverage    (low estimate – high estimate) Sub-Saharan Africa 810 000  (730 000 – 890 000) 4 700 000 17% Latin America and the Caribbean 315 000  (295 000 – 335 000) 465 000 68% East, South and South-East Asia 180 000 (150 000 – 210 000) 1 100 000 16% Europe and Central Asia 21 000  (20 000 – 22 000) 160 000 13% North Africa and the Middle East 4 000 (3 000 – 5 000) 75 000 5% Total 1 330 000 (1 200 000 –1 460 000) 6.5 million 20%

Number of people receiving ARV therapy in low and middle income countries, 2002—2005

Percentage of people on antiretroviral therapy among those in need, December 2005 Need figures for Europe are supplied by the WHO Regional Office for Europe and may differ from the ones used in the "3 by 5" progress report.

Percentage of people in sub-Saharan Africa on antiretroviral therapy among those in need

Scaling up of antiretroviral therapy in Malawi, 2003—2005

Percentage of women among all adults receiving antiretroviral therapy, 2005

Success rate of grant proposals to the Global Fund in Round 4 with and without technical support from WHO or UNAIDS Source: Global Fund to Fight AIDS, Tuberculosis and Malaria, WHO and UNAIDS.

Annual number of AIDS deaths projected among adults in sub-Saharan Africa under different intervention scenarios, 2003—2020 Source: Salomon et al. Integrating HIV prevention and treatment: from slogans to impact. PLoS Medicine, 2005, 1(2):50-56.

Trends in the cost of first-line antiretroviral therapy regimens in low-income countries, overlaid with the number of people treated, 2003—2005 700 600 Stavudine + lamivudine + 500 nevirapine (US$ per person per year) 400 Zidovudine + lamivudine + efavirenz (US$ per person per year) 300 Number of people treated at end of 200 the year (in thousands) 100 2003 2004 2005

Global HIV/AIDS spending in millions of US dollars, 1996—2004

Development of policies for collaborative TB/HIV activities in 32 countries, 2002—2004